Sodium Bicarbonate is used for: Dyspepsia; Urine alkalinisation; Severe metabolic acidosis; Hyperkalemia.
Recorded in the NepalDoc medicine catalog for Sodium Bicarbonate.
Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis.
From the U.S. FDA-approved label for Sodium Bicarbonate. Full label: DailyMed.
Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. Sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis — e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. But since an appreciable time interval may elapse before all of the ancillary effects are brought about, bicarbonate therapy is indicated to minimize risks inherent to the acidosis itself.
From the U.S. FDA-approved label for Sodium Bicarbonate. Full label: DailyMed.
Sodium Bicarbonate Injection, USP is administered by the intravenous route. In cardiac arrest, a rapid intravenous dose of 44.6 to 100 mEq may be given initially and continued at a rate of 44.6 to 50 mEq every 5 to 10 minutes if necessary (as indicated by arterial pH and blood gas monitoring) to reverse the acidosis. Caution should be observed in emergencies where very rapid infusion of large quantities of bicarbonate is indicated.
Directions from the U.S. FDA-approved label for Sodium Bicarbonate — your doctor or pharmacist may advise differently.
Sodium Bicarbonate Injection, USP is contraindicated in patients who are losing chloride by vomiting or from continuous gastrointestinal suction, and in patients receiving diuretics known to produce a hypochloremic alkalosis.
Excerpt from the U.S. FDA-approved label for Sodium Bicarbonate. Talk to a pharmacist or doctor before use.
Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency and in clinical states in which there exists edema with sodium retention. In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention. The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. Extravascular infiltration should be avoided, see ADVERSE REACTIONS.
Warnings and precautions excerpt from the U.S. FDA-approved label for Sodium Bicarbonate — not a complete list. Talk to a pharmacist or doctor before use.
Overly aggressive therapy with Sodium Bicarbonate Injection, USP can result in metabolic alkalosis (associated with muscular twitchings, irritability and tetany) and hypernatremia.
Excerpt from the U.S. FDA-approved label for Sodium Bicarbonate — not a complete list. Talk to a pharmacist or doctor about side effects.
5 brands · 4 makers in the NepalDoc catalog — see the full Sodium Bicarbonate guide →
STORE AT: 20 ° to 25 °C ( 68 ° to 77 °F). Do not freeze. For Product Inquiry: 1-800-551-7176 or www.fresenius-kabi.com/us 451554B Revised: October 2024 sodiu-img-01.jpg
Storage information from the U.S. FDA-approved label for Sodium Bicarbonate.
What is Sobica?
Sobica 300mg Tablet is a Sodium Bicarbonate medicine made by Vega Pharma. It comes as 300mg Tablet.
What is Sobica used for?
Sodium Bicarbonate is used for Dyspepsia, Urine alkalinisation, Severe metabolic acidosis, Hyperkalemia.
What is the generic name of Sobica?
The generic name of Sobica is Sodium Bicarbonate.
Which brands of Sodium Bicarbonate are available in Nepal?
5 brands of Sodium Bicarbonate are listed in the NepalDoc catalog, from 4 makers — including Sodib 7.5% Injection, Sonate 300mg Tablet, Sonate 500mg Tablet, Sucarb Ear Drop.
What are the side effects of Sodium Bicarbonate?
Overly aggressive therapy with Sodium Bicarbonate Injection, USP can result in metabolic alkalosis (associated with muscular twitchings, irritability and tetany) and hypernatremia.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
